Butao, John Ashly P.

HRN: 29-23-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFUROXIME 750MG (VIAL)
07/01/2026
07/08/2026
IV
217mg
Q8H
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: